title: Protecting the initial site of viral entry: an alternative HIV vaccine target.
authors.forename: Lucia
authors.initials: L
authors.lastname: Lopalco
authors.forename: Morgane
authors.initials: M
authors.lastname: Bomsel
mesh_terms: D016915:AIDS Vaccines / Q000008:administration & dosage* / Q000737:chemistry; D056704:Adaptive Immunity / Q000187:drug effects; D000914:Antibodies, Viral / Q000276:immunology; D000918:Antibody Specificity; D001323:Autoantibodies / Q000276:immunology; D065100:CCR5 Receptor Antagonists; D005260:Female; D005836:Genitalia, Female / Q000276:immunology; D006678:HIV / Q000187:drug effects / Q000502:physiology*; D015700:HIV Envelope Protein gp41 / Q000235:genetics / Q000276:immunology; D015658:HIV Infections / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D006801:Humans; D007113:Immunity, Innate / Q000187:drug effects; D018928:Immunity, Mucosal / Q000187:drug effects; D007070:Immunoglobulin A / Q000276:immunology; D009092:Mucous Membrane / Q000276:immunology*; D019713:Receptors, CCR5 / Q000276:immunology; D057900:Transcytosis / Q000187:drug effects; D014611:Vaccination; D053586:Virus Internalization / Q000187:drug effects*
chemical_list: D016915:AIDS Vaccines; D000914:Antibodies, Viral; D001323:Autoantibodies; D065100:CCR5 Receptor Antagonists; D015700:HIV Envelope Protein gp41; D007070:Immunoglobulin A; D019713:Receptors, CCR5